Clinical Trials Arena on MSN1d
INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participantsResults saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAB in their systems.
ExtremeTech on MSN5d
Scientists Identify Antibodies That Neutralize the Virus Behind COVID-19The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple ...
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...
News-Medical.Net on MSN1d
New laboratory tool identifies viruses to combat Staphylococcus aureusA newly developed laboratory tool can, within hours, help to identify specific viruses which can be used to destroy variants of the dangerous pathogenic bacteria Staphylococcus aureus.
“We computationally predict what mutations allow better binding to host receptors and better evasion of antibodies,” said Boston College Assistant Professor of Biology Babak Momeni, a lead researcher ...
K. Sadasivan Pillai Wednesday, March 5, 2025, 08:00 Hrs [IST] ...
Proteintech has designed recombinant antibodies featuring the company's FcZero backbone, engineered to silence the Fc domain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback